72.19.Z - Other research and experimental development on natural sciences and engineering
2019 | 2020 | 2021 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets | 6,3 | 6,3 | 6 | -5,1 |
Gross profit (loss) | 0 | 0 | 0 | 0 |
EBITDA | 0 | 0 | 0 | 0 |
Net profit (loss) | 0 | 0 | 0 | 0 |
Cash | 0,2 | 0,2 | 6 | 3222,3 |
Liabilities and provisions for liabilities | 0,9 | 0,9 | 0 | -100 |
Net income from sale | 0 | 0 | 0 | 0 |
Short time liabilities | 0,9 | 0,9 | 0 | -100 |
Working assets | 0,3 | 0,3 | 6 | 1775 |
Equity capital | 5,4 | 5,4 | 6 | 10,9 |
Operating profit (EBIT) | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 0 | 0 | 0 | 0 |
Equity capital to total assets | 85,6 | 85,6 | 100 | 14,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 0 | -2 147 483 648 |
Current financial liquidity indicator | 0.35117754340171814 | 0.35117754340171814 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane